Table S7.
Variable (group) | n | Unadjusted models
|
Adjusted models
|
||
---|---|---|---|---|---|
Estimate (95% CI) | P-value | Estimate (95% CI) | P-value | ||
FEV1 annual decline | |||||
Sustainers | 65 | (Reference) | (Reference) | ||
Slow decliners | 131 | 1.35 (0.44, 2.25) | 0.004 | 1.36 (0.46, 2.27) | 0.003 |
Rapid decliners | 65 | 1.98 (0.97, 2.98) | <0.001 | 1.91 (0.91, 2.93) | <0.001 |
DLco annual change | |||||
<25th percentile | 65 | (Reference) | (Reference) | ||
25–75th percentile | 131 | 0.77 (−0.15, 1.70) | 0.100 | 0.69 (−0.21, 1.60) | 0.133 |
>75th percentile | 65 | 0.99 (−0.05, 2.04) | 0.062 | 0.64 (−0.41, 1.68) | 0.232 |
Smoking status | |||||
Former smoker | 203 | (Reference) | (Reference) | ||
Continuous/intermittent smoker | 58 | 0.24 (−0.22, 0.71) | 0.304 | 0.27 (−0.18, 0.73) | 0.234 |
Annual change in BMI | |||||
<25th percentile | 65 | (Reference) | (Reference) | ||
25–75th percentile | 131 | 0.57 (−0.38, 1.52) | 0.239 | 0.24 (−0.68, 1.15) | 0.613 |
>75th percentile | 65 | 0.50 (−0.58, 1.57) | 0.362 | 0.37 (−0.68, 1.42) | 0.490 |
Exacerbation | (Admission definition, in 5 years) | ||||
Negative | 232 | (Reference) | (Reference) | ||
Positive | 29 | 0.75 (0.14, 1.36) | 0.016 | 0.93 (0.32, 1.54) | 0.003 |
Use of anticholinergics | |||||
Not use | 126 | (Reference) | (Reference) | ||
Use | 135 | 0.16 (−0.22, 0.54) | 0.402 | −0.02 (−0.40, 0.37) | 0.934 |
Use of beta agonists | |||||
Not use | 169 | (Reference) | (Reference) | ||
Use | 92 | 0.22 (−0.18, 0.62) | 0.274 | 0.21 (−0.20, 0.62) | 0.313 |
Abbreviations: BMI, body mass index; CI, confidence interval; DLco, carbon monoxide diffusing capacity; FEV1, forced expiratory volume in 1 second; SGRQ, St George’s Respiratory Questionnaire.